Literature DB >> 9371827

Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.

R Roberts1, N A Timchenko, J W Miller, S Reddy, C T Caskey, M S Swanson, L T Timchenko.   

Abstract

Myotonic dystrophy (DM) is associated with expansion of CTG repeats in the 3'-untranslated region of the myotonin protein kinase (DMPK) gene. The molecular mechanism whereby expansion of the (CUG)n repeats in the 3'-untranslated region of DMPK gene induces DM is unknown. We previously isolated a protein with specific binding to CUG repeat sequences (CUG-BP/hNab50) that possibly plays a role in mRNA processing and/or transport. Here we present evidence that the phosphorylation status and intracellular distribution of the RNA CUG-binding protein, identical to hNab50 protein (CUG-BP/hNab50), are altered in homozygous DM patient and that CUG-BP/hNab50 is a substrate for DMPK both in vivo and in vitro. Data from two biological systems with reduced levels of DMPK, homozygous DM patient and DMPK knockout mice, show that DMPK regulates both phosphorylation and intracellular localization of the CUG-BP/hNab50 protein. Decreased levels of DMPK observed in DM patients and DMPK knockout mice led to the elevation of the hypophosphorylated form of CUG-BP/hNab50. Nuclear concentration of the hypophosphorylated CUG-BP/hNab50 isoform is increased in DMPK knockout mice and in homozygous DM patient. DMPK also interacts with and phosphorylates CUG-BP/hNab50 protein in vitro. DMPK-mediated phosphorylation of CUG-BP/hNab50 results in dramatic reduction of the CUG-BP2, hypophosphorylated isoform, accumulation of which was observed in the nuclei of DMPK knockout mice. These data suggest a feedback mechanism whereby decreased levels of DMPK could alter phosphorylation status of CUG-BP/hNab50, thus facilitating nuclear localization of CUG-BP/hNab50. Our results suggest that DM pathophysiology could be, in part, a result of sequestration of CUG-BP/hNab50 and, in part, of lowered DMPK levels, which, in turn, affect processing and transport of specific subclass of mRNAs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371827      PMCID: PMC24290          DOI: 10.1073/pnas.94.24.13221

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Myotonic dystrophy: discussion of molecular mechanism.

Authors:  C T Caskey; M S Swanson; L T Timchenko
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1996

2.  Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy.

Authors:  Y H Fu; D L Friedman; S Richards; J A Pearlman; R A Gibbs; A Pizzuti; T Ashizawa; M B Perryman; G Scarlato; R G Fenwick
Journal:  Science       Date:  1993-04-09       Impact factor: 47.728

3.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

4.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

5.  Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring.

Authors:  J B Redman; R G Fenwick; Y H Fu; A Pizzuti; C T Caskey
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

6.  The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy.

Authors:  A Hunter; C Tsilfidis; G Mettler; P Jacob; M Mahadevan; L Surh; R Korneluk
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

7.  Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.

Authors:  J Buxton; P Shelbourne; J Davies; C Jones; T Van Tongeren; C Aslanidis; P de Jong; G Jansen; M Anvret; B Riley
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

8.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect.

Authors:  C Aslanidis; G Jansen; C Amemiya; G Shutler; M Mahadevan; C Tsilfidis; C Chen; J Alleman; N G Wormskamp; M Vooijs
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

9.  Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.

Authors:  C Tsilfidis; A E MacKenzie; G Mettler; J Barceló; R G Korneluk
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  50 in total

Review 1.  Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Authors:  R P Junghans; A Ebralidze; B Tiwari
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

Review 2.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  Structural genomics analysis of alternative splicing and application to isoform structure modeling.

Authors:  Peng Wang; Bo Yan; Jun-Tao Guo; Chindo Hicks; Ying Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

4.  In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.

Authors:  M Fardaei; K Larkin; J D Brook; M G Hamshere
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

5.  Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene.

Authors:  T A Cooper
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 6.  Myotonic dystrophy: the role of RNA CUG triplet repeats.

Authors:  L T Timchenko
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  Molecular biology of heart disease.

Authors:  Robert Roberts
Journal:  World J Cardiol       Date:  2011-04-26

Review 8.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

9.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 10.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.